Navigation Links
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Date:6/8/2011

both in the US and abroad (in Asia, Europe and Israel), are at the forefront of clinical trials and early commercialization.  Ms. Powers has served for years on a number of related boards, including the M2Gen Board of the Moffitt Cancer Center, the Board of the Trudeau Institute (a world leader in immunology research) and others.  As Chairman of NWBT, she has brought her lengthy experience to bear in helping to shape NWBT's overall strategy and programs.  As CEO, she will now undertake operational responsibilities in addition to continuing her duties as Chairman.

Dr. Alton Boynton is the scientific founder of NWBT, and was the first in the world to conduct a clinical trial with dendritic cells – the master cells of the immune system, which are the cells used in NWBT's DCVax® products.  During the 1990s, when little was known about dendritic cells and their roles, Dr. Boynton's research lab was an early leader in identifying the important clinical capabilities of the dendritic cells and their potential for fighting cancer.  Within this academic setting, during the 1990s Dr. Boynton treated over 100 prostate cancer patients with the DCVax® technology, prior to commencing formal clinical trials in the Company.  Since that time,  Dr. Boynton served as the Chief Scientific Officer of the Company until 2007, at which time he became CEO.  Prior to founding NWBT, Dr. Boynton headed the Molecular Oncology research lab at the Pacific Northwest Research Foundation (the original foundation of Bill Hutchinson, from which the Fred Hutchinson Cancer Center was spun off), focusing on dendritic cells, and he established and headed the Molecular Oncology research department at Northwest Hospital in Seattle (where the first clinical trial with dendritic cells took place in 1995).  Earlier in his career, Dr. Boynton was Associate Director of the University of Hawaii Cancer Center, and a professor of Genetics and Molec
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Northwestern chemists take gold, mass-produce Beijing Olympic logo
2. Northwest Secures US$1.0 Million Debt Financing
3. Northwest Secures US$1.65 Million Debt Financing
4. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
5. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
6. Northwest Biotherapeutics Secures $700,000 Equity Financing
7. Sirius Genomics to Present at Invest Northwest Conference
8. Oncothyreon to present at Invest Northwest 2009
9. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
10. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
11. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... observed the fractional quantum Hall effect in bilayer graphene ... be tuned by an electric field. , The ... confined to thin sheets are exposed to large magnetic ... thousands of individual electrons behave as a single system. ... well established, many details of this collective behavior remain ...
(Date:7/10/2014)... theatergoers have shelled out for crude 3-D glasses, ... viewing experience. These basic devices, used to trick ... may soon be rendered obsolete with the introduction ... University researchers. , TAU doctoral students Yuval Yifat, ... efficient holography based on nanoantennas that could be ...
(Date:1/15/2014)... to assembling a club sandwich at the nanoscale, ... have succeeded in crafting a uniform, multi-walled carbon-nanotube-based ... commonly used in upholstered furniture and other soft ... foam was reduced 35 percent compared with untreated ...
(Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
Breaking Biology Technology:Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3
... CRANBURY, N.J., March 11 Amicus Therapeutics (Nasdaq: ... and Chief Executive Officer John F. Crowley will be ... Healthcare Conference. Mr. Crowley,s presentation is scheduled to ... Time.Individuals can listen to a live webcast of the ...
... CITY, March 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... on endocrinology and oncology, today reported financial and operating results for ... 2008 Highlights, - February, ... a Phase 2 trial in advanced, ...
... Wednesday, March 11, 2009 at 4:30 p.m. Eastern TimeBOTHELL, ... Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ... 2008 financial results, reviewed the Company,s highlights and provided ... active year from an execution standpoint as we took ...
Cached Biology Technology:AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 2AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 3AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 4AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 5AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 6AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 7AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 8AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 9AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results 10OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 2OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 3OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 4OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 5OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 6OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 7OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 8OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 9OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 10OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 11OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009 12
(Date:7/10/2014)... of overfishing in the English Channel has resulted in ... and left fishermen ,scraping the barrel, for increasing amounts ... cod, haddock and many other species at the head ... many removed from the area completely., These are some ... biologists at Plymouth University, in association with international non-profit ...
(Date:7/10/2014)... even if you are a big, bad sea scorpion. ... shallow waters for any prey in sight. The next, ... scientists, you,re reduced to trolling for weaker, soft-bodied animals ... lot of the giant pterygotid eurypterid, the largest arthropod ... published in the journal Biology Letters , dramatically ...
(Date:7/10/2014)... Endomedix, a start-up company housed at NJIT,s business incubator, ... spray-on gel that surgeons will use to staunch bleeding ... onto a surgical site, and the natural bio-polymer solutions ... the patient within 30 seconds. , The gel ... It will translate into less time for the patient,s ...
Breaking Biology News(10 mins):Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 2Overfishing in the English Channel leaves fisherman scraping the bottom of the barrel 3Extinct sea scorpion gets a Yale eye exam, with surprising results 2A start-up at NJIT develops bleeding-control gel for brain surgery 2
... effect of cocaine on mice by genetically manipulating a ... , While the researchers aren't suggesting that these genetic ... light the key protein that controls cocaine's effects in ... achieve the same results and therefore help addicts overcome ...
... plant species are not only more productive, they are ... extremes, pests and disease over long periods of time. ... of Nature, are the culmination of 12 years of ... at the University of Minnesota, to explore the value ...
... the genes in the fruitfly genome, Johns Hopkins scientists have ... and simultaneously captured a global view of all the genes ... The study, to be published April 3 in Developmental Cell, ... cells that move similarly to spread beyond an original tumor, ...
Cached Biology News:Genetically altered mice no longer like cocaine 2Genetically altered mice no longer like cocaine 3Biodiversity key to sustainable biofuel according to University of Minn. researcher's findings 2Researchers identify genes in fruitflies that may shed light on human cancer spread 2
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Request Info...
Human Cell Line Slides...
... Detection System combines the indirect labeling ... and Signets unique formulation of ultra ... reliablility. Signet reagents will achieve excellent ... automated protocols. ,Signets USA Detection reagents ...
Biology Products: